RE: Actuate Therapeutics Inc2 Jul 2026 00:23
Close $1.44...-5.88%
Todays Low was $1.4
Topped up again for *$1.47
23/6/26 Buy 1.95
12/6/26 Sell 2.3 Spiked to 2.78 !!
Did not post last two trades .
.....................................................
28/5/26 Buy 2
Chart does not show comment below .
Actuate Therapeutics advanced following compelling clinical data for its lead candidate, elraglusib, presented at the 2026 ASCO meeting. These positive efficacy signals in metastatic pancreatic cancer act as primary catalysts. Market sentiment suggests a bullish outlook for the next quarter as analysts project further development progress and potential regulatory milestones for elraglusib.